Domainex

About:

A fully integrated drug discovery service company.

Top Investors: Innovate UK, YFM Equity Partners, Takeda Ventures, Longbow Capital, UCLB

Description:

Domainex Ltd is a contract research company that was established in 2001 and operates from Cambridge UK. In May 2007 Domainex merged with NCE Discovery to form a new integrated company with capabilities in biology and chemistry. Service division offers technologies designed to clone and express challenging genes to give high-quality recombinant protein displaying functional domains of the target. We also provide computational and medicinal chemistry for the design and synthesis of candidate drugs aimed at our customers' target proteins.

Total Funding Amount:

$5.65M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2001-01-01

Contact Email:

enquiries(AT)domainex.co.uk

Founders:

Chrisostomos Prodromou, Laurence Pearl, Paul Driscoll, Renos Savva

Number of Employees:

11-50

Last Funding Date:

2018-01-23

IPO Status:

Private

Industries: